The level of serum Tumor Marker CA15-3 in women with Breast Cancer

عرض إصدارات أخرى (1)

Background: Breast cancer is the most frequently diagnosed type of cancer in women in all world regions. About 1.7 million cases of breast cancer are diagnosed every year. Breast cancer is the most common cause of death in women worldwide. There were approximately 0.5 million deaths worldwide from...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:	Diyala Journal of Medicine
المؤلفون الرئيسيون:	Huda Hameed Othman, Walaa Najm Abood, Nazar Abdul Hassan Alwakeel
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	College of medicine/ University of Diyala 2018-10-01
الموضوعات:	Breast Cancer, Tumor Marker, CA15-3.
الوصول للمادة أونلاين:	https://www.djm.uodiyala.edu.iq/index.php/djm/article/view/160

مواد مشابهة

The level of serum Tumor Marker CA15-3 in women with Breast Cancer
حسب: Huda Hameed Othman, وآخرون
منشور في: (2018-10-01)

Reliability of CA15-3 Tumor Marker in Monitoring Therapeutic Response in Different Molecular Subtypes of Metastatic Breast Cancer
حسب: Alya Al Zobair, وآخرون
منشور في: (2022-07-01)

Evaluation of Preoperative CA15-3 Level and its Relationship with Clinico-Pathological Characteristics in Primary Breast Cancer Patients
حسب: Braihan Hamdi Hameed, وآخرون
منشور في: (2022-06-01)

Independent prognostic impact of preoperative serum carcinoembryonic antigen and cancer antigen 15-3 levels for early breast cancer subtypes
حسب: Michiko Imamura, وآخرون
منشور في: (2018-02-01)

Dyslipidemia and CA15-3 serum level in Iraqi Women with Breast Tumor: A Comparative Study
حسب: Aseel N. Kamil, وآخرون
منشور في: (2018-12-01)

Early detection of Breast Cancer by Tumor Marker CA15.3, CA27.29 and relationship with P53 and Vitamin D
حسب: Ryaidh Sh. Al-Hussain, وآخرون
منشور في: (2014-01-01)

Study of Glutathione S-Transferase, Its Isoenzyme (Pi), and Tumor Markers (CA15-3, HE4) in Breast Carcinoma Patients (Before and After Treatment)
حسب: Dattu Hawale, وآخرون
منشور في: (2025-05-01)

Sensitivity and Specificity of CA 15-3 in Detection of Breast Cancer Recurrence
حسب: Sh. Omidvari, وآخرون
منشور في: (2005-07-01)

Differences in Ca 15-3 and Homocysteine Levels in Patients with Benign Tumor and Breast Cancer
حسب: Mathink Toonov ANUGERAWATI, وآخرون
منشور في: (2024-03-01)

Correlation between CA-15-3 and Bone Scan findings in patients with Carcinoma Breast
حسب: Julekha Khatun, وآخرون
منشور في: (2022-05-01)

A case of ductal carcinoma in situ (DCIS) with markedly elevated CA15-3 levels requiring 2 years of diagnosis
حسب: Mutsumi Fujimoto, وآخرون
منشور في: (2023-12-01)

Method Comparison and Clinical Performance of Breast Cancer Tumor Markers on Novel Multiplex Immunoassay and Automatized LOCI Technology Platforms
حسب: Lars Schröder, وآخرون
منشور في: (2023-09-01)

Longitudinal evaluation of external quality assessment results for CA 15-3, CA 19-9, and CA 125
حسب: Marcel Kremser, وآخرون
منشور في: (2024-06-01)

Association of neutrophils, monocytes, and lymphocytes with CA15-3 as a predictor of breast cancer in female patients
حسب: Raed Madhi, وآخرون
منشور في: (2024-03-01)

Determination of Cancer Antigen CA15-3 and Carcino Embryonic Antigen CEA concentration as Tumor Markers in Patients with Stomach and Colorectal cancers.
حسب: Rana. K. AL-saady, وآخرون
منشور في: (2012-10-01)

Study of Glutathione S-Transferase, its Isoenzyme (Pi) and Tumor Marker (CA15-3, HE4) in Breast Carcinoma Patients (Before and After Treatment)
حسب: Dattu Hawale, وآخرون
منشور في: (2025-05-01)

Avaliação comparativa de dosagem do marcador tumoral CA 15-3 em cadelas hígidas ou com neoplasia mamária
حسب: Gabriela B. Roberto, وآخرون

Hubungan Kadar Cancer Antigen 15-3 Serum dengan Metastasis Kanker Payudara
حسب: Fakhriyyatur Rahmi M, وآخرون
منشور في: (2021-05-01)

Study of Glutathione S-Transferase, Its Isoenzyme (Pi) and Tumor Marker (CA15-3, HE4) in Breast Carcinoma Patients (Before and After Treatment)
حسب: Dattu Hawale, وآخرون
منشور في: (2025-05-01)

Primary Cutaneous Mucinous Carcinoma Monitoring: A Role for CA15.3 and CEA?
حسب: Antonin Ginguay, وآخرون
منشور في: (2022-12-01)

Tumor biomarkers CEA, CA19.9, CA15.3 and AFP levels in the serum of patients with COVID-19
حسب: Abubaker H. Ali, وآخرون
منشور في: (2022-04-01)

Diagnostic and prognostic value of neutrophil gelatinase associated lipocalin and cancer antigen 15-3 serum levels in benign and malignant breast disease
حسب: Tunc Eren, وآخرون
منشور في: (2016-03-01)

Time Series measurements of White Blood Cells (WBC) and plasma Cancer Antigen 15-3 (CA 15-3) in a patient with metastatic breast cancer, serving as a reference for assessing the clinical relevance of different clustering algorithms.
حسب: Alexandros CLOUVAS
منشور في: (2024-12-01)

Exploring The Impact of Capecitabine Treatment on Hormonal and Biochemical Markers in Women with Breast Cancer
حسب: Raaid Fadhl Abbas Masoudi, وآخرون
منشور في: (2023-11-01)

Discovery of a Sinusoidal Pattern in the Cancer Antigen 15-3 Time Series of a Patient with Metastatic Breast Cancer
حسب: Alexandros CLOUVAS
منشور في: (2025-05-01)

CA 19-9 as a serum marker in urothelial carcinoma
حسب: Mahander Pall, وآخرون
منشور في: (2012-01-01)

Serum Hepcidin Levels in Breast Cancer Patients: Investigating the Correlation to Tumor Stage—A Cross‐Sectional Study
حسب: Zein Al‐Abideen Douba, وآخرون
منشور في: (2025-08-01)

Clinical validation of the novel CLIA-CA-62 assay efficacy for early-stage breast cancer detection
حسب: Marina Sekacheva, وآخرون
منشور في: (2023-05-01)

The possible role of tumor antigen CA 15-3, CEA and ferritin in malignant and benign disease
حسب: Nafija Serdarević, وآخرون
منشور في: (2012-09-01)

A High-Sensitivity, Bluetooth-Enabled PCB Biosensor for HER2 and CA15-3 Protein Detection in Saliva: A Rapid, Non-Invasive Approach to Breast Cancer Screening
حسب: Hsiao-Hsuan Wan, وآخرون
منشور في: (2025-06-01)

Exploring the Significance of Cluster Analysis on Time-Series Measurement of Plasma Cancer Antigen 15-3 in a Patient with Metastatic Breast Cancer
حسب: Alexandros CLOUVAS
منشور في: (2024-09-01)

Disposable Voltammetric Immunosensor for Determination and Quantification of Biomarker CA 15-3 in Biological Specimens
حسب: Ana Elisa F. Oliveira, وآخرون
منشور في: (2024-02-01)

Clinical impact of PTEN methylation status as a prognostic marker for breast cancer
حسب: Amal Ramadan, وآخرون
منشور في: (2021-05-01)

Tumor Markers in Dogs with Mammary Gland Tumors
حسب: Valencakova Alexandra, وآخرون
منشور في: (2023-12-01)

Practical application of the CA-62 tumor marker in the initial diagnosis of oncological disease of epithelial origin: assistance to the doctor in interpreting the results
حسب: Janneta R. Tcherkassova, وآخرون
منشور في: (2023-06-01)

Platinum nanoparticles decorated on electrodeposited Ti3C2Tx MXene nanosheets as an ultrasensitive biosensor for CA15–3 detection
حسب: Sepideh Shafaei, وآخرون
منشور في: (2025-06-01)

Perbandingan Uji Diagnostik Mesothelin Serum dengan CA-125 pada Kanker Ovarium Tipe Epitel
حسب: ERI PERDANA USHAN, وآخرون
منشور في: (2015-05-01)

Association of Serum Leptin and C-Reactive Protein in Women with Breast Cancer
حسب: Zainab M Al-Shammaa, وآخرون
منشور في: (2018-06-01)

Utility of CA15-3 as a Tumour Proliferation Marker in Breast Carcinoma Patients: A Cross-sectional Study Protocol
حسب: Apoorva Pande, وآخرون
منشور في: (2025-08-01)

Risk of early progression according to circulating ESR1 mutation, CA-15.3 and cfDNA increases under first-line anti-aromatase treatment in metastatic breast cancer
حسب: Florian Clatot, وآخرون
منشور في: (2020-05-01)